Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13063-019-3409-1.

Title:
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy | Trials
Description:
Background HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. Methods/design This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12 weeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12 weeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNγ ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. Discussion This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. Trial registration EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

hiv, study, article, patients, viral, cart, ihivarna, tcell, week, google, scholar, vaccination, trial, treatment, immune, responses, trimix, interruption, control, mrna, weeks, virus, patient, cas, safety, therapy, van, vaccine, hti, investigator, hivinfected, load, infection, prior, data, including, full, injection, immunotherapy, days, consent, phase, cells, active, dcs, clinical, barcelona, adverse, ati, period,

Topics {✒️}

int/hiv/pub/progressreports/2016-progress-report/en/ prominent lymph node cross-presenting dendritic cells immunogen-specific t-cell response hiv-specific t-cell responses hti-specific t-cell responses broad t-cell specificities broad variant cross-reactivity patient-derived cd8+ t-cells induce t-cell responses hivacat t-cell immunogen int/hiv/data/en/ potent cancer immunotherapy mrna expression profiles dc-based vaccine offers org/guide/hiv-classification-cdc nadir cd4+ ≥ 350 cells/μl enhance t-cell activation t-cell elispot essay t-cell stimulatory capacity ad26/mva therapeutic vaccination activating specific t-cells hiv-specific t-cells beatriz mothe chronic hiv-infected patients autologous b-cells expressing nonsteroidal anti-inflammatory drugs positive-sense ribonucleic acid vaccine-induced immune response siv-infected rhesus monkeys highly hiv-exposed individuals coincident ad26/mva vaccination lysing hiv-infected cells vitals/lymph nodes lay-man interpretable results early-treated hiv-1 infection t-cell responses cd4+ cell counts vaccine-induced immune pressure article download pdf double-stranded deoxyribonucleic acid conduct sieve-effect analyses phase-iia clinical trial hti vaccines combined chronically hiv-infected patients t-cell immunogen hiv-1 infection induces called “blips” ≤ 500 copies/ml author information authors high functional avidity

Schema {🗺️}

WebPage:
      mainEntity:
         headline:iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
         description:HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12 weeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12 weeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNÎł ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
         datePublished:2019-06-17T00:00:00Z
         dateModified:2019-12-13T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13063-019-3409-1
         keywords:
            HIV-1
            Therapeutic vaccine
            Functional cure
            Immunotherapy
            Reservoir
            Lymph node
            TriMix
            Antigen-presenting cell
            Medicine/Public Health
            general
            Biomedicine
            Statistics for Life Sciences
            Medicine
            Health Sciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig2_HTML.png
         isPartOf:
            name:Trials
            issn:
               1745-6215
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Wesley de Jong
               url:http://orcid.org/0000-0001-9674-2647
               affiliation:
                     name:Erasmus MC
                     address:
                        name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joeri Aerts
               affiliation:
                     name:Vrije Universiteit Brussel
                     address:
                        name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sabine Allard
               affiliation:
                     name:Universitair Ziekenhuis Brussel
                     address:
                        name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Brander
               affiliation:
                     name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
                     address:
                        name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
                        type:PostalAddress
                     type:Organization
                     name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA)
                     address:
                        name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona
                     address:
                        name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:University of Vic – Central University of Catalonia (UVic-UCC)
                     address:
                        name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jozefien Buyze
               affiliation:
                     name:Institute of Tropical Medicine and
                     address:
                        name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
                     name:University of Antwerp
                     address:
                        name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric Florence
               affiliation:
                     name:Institute of Tropical Medicine and
                     address:
                        name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
                     name:University of Antwerp
                     address:
                        name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric van Gorp
               affiliation:
                     name:Erasmus MC
                     address:
                        name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido Vanham
               affiliation:
                     name:Institute of Tropical Medicine and
                     address:
                        name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
                     name:University of Antwerp
                     address:
                        name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lorna Leal
               affiliation:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                     address:
                        name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Hospital ClĂ­nic
                     address:
                        name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Beatriz Mothe
               affiliation:
                     name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
                     address:
                        name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
                        type:PostalAddress
                     type:Organization
                     name:University of Vic – Central University of Catalonia (UVic-UCC)
                     address:
                        name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kris Thielemans
               affiliation:
                     name:Vrije Universiteit Brussel
                     address:
                        name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Montse Plana
               affiliation:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                     address:
                        name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:FĂŠlipe Garcia
               affiliation:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                     address:
                        name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Hospital ClĂ­nic
                     address:
                        name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Rob Gruters
               affiliation:
                     name:Erasmus MC
                     address:
                        name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
      description:HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12 weeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12 weeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNÎł ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
      datePublished:2019-06-17T00:00:00Z
      dateModified:2019-12-13T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13063-019-3409-1
      keywords:
         HIV-1
         Therapeutic vaccine
         Functional cure
         Immunotherapy
         Reservoir
         Lymph node
         TriMix
         Antigen-presenting cell
         Medicine/Public Health
         general
         Biomedicine
         Statistics for Life Sciences
         Medicine
         Health Sciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig2_HTML.png
      isPartOf:
         name:Trials
         issn:
            1745-6215
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Wesley de Jong
            url:http://orcid.org/0000-0001-9674-2647
            affiliation:
                  name:Erasmus MC
                  address:
                     name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joeri Aerts
            affiliation:
                  name:Vrije Universiteit Brussel
                  address:
                     name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sabine Allard
            affiliation:
                  name:Universitair Ziekenhuis Brussel
                  address:
                     name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Brander
            affiliation:
                  name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
                  address:
                     name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
                     type:PostalAddress
                  type:Organization
                  name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA)
                  address:
                     name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona
                  address:
                     name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:University of Vic – Central University of Catalonia (UVic-UCC)
                  address:
                     name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jozefien Buyze
            affiliation:
                  name:Institute of Tropical Medicine and
                  address:
                     name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
                  name:University of Antwerp
                  address:
                     name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric Florence
            affiliation:
                  name:Institute of Tropical Medicine and
                  address:
                     name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
                  name:University of Antwerp
                  address:
                     name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric van Gorp
            affiliation:
                  name:Erasmus MC
                  address:
                     name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido Vanham
            affiliation:
                  name:Institute of Tropical Medicine and
                  address:
                     name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
                  name:University of Antwerp
                  address:
                     name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lorna Leal
            affiliation:
                  name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                  address:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Hospital ClĂ­nic
                  address:
                     name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Beatriz Mothe
            affiliation:
                  name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
                  address:
                     name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
                     type:PostalAddress
                  type:Organization
                  name:University of Vic – Central University of Catalonia (UVic-UCC)
                  address:
                     name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kris Thielemans
            affiliation:
                  name:Vrije Universiteit Brussel
                  address:
                     name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Montse Plana
            affiliation:
                  name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                  address:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:FĂŠlipe Garcia
            affiliation:
                  name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
                  address:
                     name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Hospital ClĂ­nic
                  address:
                     name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Rob Gruters
            affiliation:
                  name:Erasmus MC
                  address:
                     name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Trials
      issn:
         1745-6215
      volumeNumber:20
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Erasmus MC
      address:
         name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
         type:PostalAddress
      name:Vrije Universiteit Brussel
      address:
         name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
         type:PostalAddress
      name:Universitair Ziekenhuis Brussel
      address:
         name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
         type:PostalAddress
      name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
      address:
         name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
         type:PostalAddress
      name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA)
      address:
         name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
         type:PostalAddress
      name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona
      address:
         name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:University of Vic – Central University of Catalonia (UVic-UCC)
      address:
         name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
         type:PostalAddress
      name:Institute of Tropical Medicine and
      address:
         name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
         type:PostalAddress
      name:University of Antwerp
      address:
         name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
      name:Institute of Tropical Medicine and
      address:
         name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
         type:PostalAddress
      name:University of Antwerp
      address:
         name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
      name:Erasmus MC
      address:
         name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
         type:PostalAddress
      name:Institute of Tropical Medicine and
      address:
         name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
         type:PostalAddress
      name:University of Antwerp
      address:
         name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
      address:
         name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
         type:PostalAddress
      name:Hospital ClĂ­nic
      address:
         name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
         type:PostalAddress
      name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
      address:
         name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
         type:PostalAddress
      name:University of Vic – Central University of Catalonia (UVic-UCC)
      address:
         name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
         type:PostalAddress
      name:Vrije Universiteit Brussel
      address:
         name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
         type:PostalAddress
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
      address:
         name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
         type:PostalAddress
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
      address:
         name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
         type:PostalAddress
      name:Hospital ClĂ­nic
      address:
         name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
         type:PostalAddress
      name:Erasmus MC
      address:
         name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Wesley de Jong
      url:http://orcid.org/0000-0001-9674-2647
      affiliation:
            name:Erasmus MC
            address:
               name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Joeri Aerts
      affiliation:
            name:Vrije Universiteit Brussel
            address:
               name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Sabine Allard
      affiliation:
            name:Universitair Ziekenhuis Brussel
            address:
               name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Christian Brander
      affiliation:
            name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
            address:
               name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
               type:PostalAddress
            type:Organization
            name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA)
            address:
               name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona
            address:
               name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:University of Vic – Central University of Catalonia (UVic-UCC)
            address:
               name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
               type:PostalAddress
            type:Organization
      name:Jozefien Buyze
      affiliation:
            name:Institute of Tropical Medicine and
            address:
               name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
               type:PostalAddress
            type:Organization
            name:University of Antwerp
            address:
               name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Eric Florence
      affiliation:
            name:Institute of Tropical Medicine and
            address:
               name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
               type:PostalAddress
            type:Organization
            name:University of Antwerp
            address:
               name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Eric van Gorp
      affiliation:
            name:Erasmus MC
            address:
               name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Guido Vanham
      affiliation:
            name:Institute of Tropical Medicine and
            address:
               name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
               type:PostalAddress
            type:Organization
            name:University of Antwerp
            address:
               name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Lorna Leal
      affiliation:
            name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
            address:
               name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Hospital ClĂ­nic
            address:
               name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Beatriz Mothe
      affiliation:
            name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
            address:
               name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
               type:PostalAddress
            type:Organization
            name:University of Vic – Central University of Catalonia (UVic-UCC)
            address:
               name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
               type:PostalAddress
            type:Organization
      name:Kris Thielemans
      affiliation:
            name:Vrije Universiteit Brussel
            address:
               name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Montse Plana
      affiliation:
            name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
            address:
               name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:FĂŠlipe Garcia
      affiliation:
            name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
            address:
               name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Hospital ClĂ­nic
            address:
               name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Rob Gruters
      affiliation:
            name:Erasmus MC
            address:
               name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
      name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
      name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
      name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
      name:InstituciĂł Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
      name:AELIX Therapeutics, Parc CientĂ­fic de Barcelona, Barcelona, Spain
      name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
      name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
      name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
      name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
      name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
      name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
      name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
      name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
      name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
      name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
      name:University of Vic – Central University of Catalonia (UVic-UCC), Vic, Spain
      name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
      name:Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
      name:Infectious Diseases Unit, Hospital ClĂ­nic, Barcelona, Spain
      name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands

External Links {🔗}(112)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Particles.js
  • Prism.js

CDN Services {📦}

  • Crossref

6.54s.